A team of international scientists has developed a method to predict the risk of developing cancer from a blood disorder common in older adults, according to a study published in the journal Blood.

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

Researchers discovered distinct molecular differences in how the brain processes directly experienced versus witnessed trauma -- a finding that could lead to more targeted treatments for PTSD.

Inflammation may be at the core of cognitive decline as recent studies offer clues on how herpes simplex virus-1, antibiotics, antivirals, and vaccines may have different effect on dementia risk.

Darzalex and Revlimid maintenance resulted in superior outcomes versus Revlimid alone following autologous stem cell ...

Neurodegenerative diseases represent a significant challenge in medical science, impacting millions globally. Despite advancements in diagnostic technology, ...

Current FDA approval of this adaptive system is for the treatment of Parkinson’s only, not essential tremor, dystonia (a ...

In the April issue of SciAm, follow a man’s journey to a diagnosis, learn about exciting new schizophrenia treatments, and ...

In Nature Neuroscience, UConn School of Medicine researchers have revealed a new scientific clue that could unlock the key cellular pathway leading to devastating neurodegenerative diseases like ...

In a recently published review, researchers led by Prof. Wu Qingfeng at the Institute of Genetics and Developmental Biology ...